Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanna Riccardi

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Current Opinion in Microbiology|August 9, 2011
New tuberculosis drugs on the horizonStewart T Cole, Giovanna Riccardi
The Journal of Antibiotics|August 7, 2014
Trends in discovery of new drugs for tuberculosis therapyGiovanna Riccardi, Maria Rosalia Pasca
Applied Microbiology and Biotechnology|October 15, 2011
Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacteriumSilvia Bazzini, Claudia Udine, Giovanna Riccardi
Future Microbiology|June 5, 2009
Mycobacterium tuberculosis: drug resistance and future perspectivesGiovanna Riccardi, Maria Rosalia Pasca, Silvia Buroni
Drug Discovery Today|September 25, 2016
Raising awareness of the importance of funding for tuberculosis small-molecule researchGiovanna Riccardi, Iain G Old, Sean Ekins
FEMS Microbiology Reviews|January 28, 2006
Role of mycobacterial efflux transporters in drug resistance: an unresolved questionEdda De Rossi, José A Aínsa, Giovanna Riccardi
BMC Microbiology|March 5, 2009
Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatisAnna Maciag, Aurora Piazza, Giovanna Riccardi, et al.
Journal of Bacteriology|August 4, 2005
Rv2358 and FurB: two transcriptional regulators from Mycobacterium tuberculosis which respond to zincFabio Canneva, Manuela Branzoni, Giovanna Riccardi, et al.
Research in Microbiology|April 3, 2004
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zincAnna Milano, Manuela Branzoni, Fabio Canneva, et al.
Drug Discovery Today|September 22, 2016
New prodrugs against tuberculosisGiorgia Mori, Laurent Roberto Chiarelli, Giovanna Riccardi, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Current Opinion in Microbiology|August 9, 2011
New tuberculosis drugs on the horizonStewart T Cole, Giovanna Riccardi
The Journal of Antibiotics|August 7, 2014
Trends in discovery of new drugs for tuberculosis therapyGiovanna Riccardi, Maria Rosalia Pasca
Applied Microbiology and Biotechnology|October 15, 2011
Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacteriumSilvia Bazzini, Claudia Udine, Giovanna Riccardi
Future Microbiology|June 5, 2009
Mycobacterium tuberculosis: drug resistance and future perspectivesGiovanna Riccardi, Maria Rosalia Pasca, Silvia Buroni
Drug Discovery Today|September 25, 2016
Raising awareness of the importance of funding for tuberculosis small-molecule researchGiovanna Riccardi, Iain G Old, Sean Ekins
FEMS Microbiology Reviews|January 28, 2006
Role of mycobacterial efflux transporters in drug resistance: an unresolved questionEdda De Rossi, José A Aínsa, Giovanna Riccardi
BMC Microbiology|March 5, 2009
Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatisAnna Maciag, Aurora Piazza, Giovanna Riccardi, et al.
Journal of Bacteriology|August 4, 2005
Rv2358 and FurB: two transcriptional regulators from Mycobacterium tuberculosis which respond to zincFabio Canneva, Manuela Branzoni, Giovanna Riccardi, et al.
Research in Microbiology|April 3, 2004
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zincAnna Milano, Manuela Branzoni, Fabio Canneva, et al.
Drug Discovery Today|September 22, 2016
New prodrugs against tuberculosisGiorgia Mori, Laurent Roberto Chiarelli, Giovanna Riccardi, et al.
Pageof 7